Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry B Gernsheimer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Blood|July 10, 2024
RBCs regulate platelet function and hemostasis under shear conditions through biophysical and biochemical meansDebbie Jiang, Katie L Houck, Lydia Murdiyarso, et al.
Blood Advances|August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopeniaAnton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Transfusion|September 12, 2018
Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopeniaSherrill J Slichter, Larry J Dumont, Jose A Cancelas, et al.
American Journal of Hematology|January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B StudyNichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Leukemia & Lymphoma|September 14, 2020
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Nicholas P Howard, et al.
The Journal of Trauma and Acute Care Surgery|May 27, 2021
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus ConferencePhilip C Spinella, Nahed El Kassar, Andrew P Cap, et al.
Blood|October 23, 2009
International consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Roberto Stasi, Adrian C Newland, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Leukemia|October 6, 2019
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasmAnna B Halpern, Nicholas P Howard, Megan Othus, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood|July 10, 2024
RBCs regulate platelet function and hemostasis under shear conditions through biophysical and biochemical meansDebbie Jiang, Katie L Houck, Lydia Murdiyarso, et al.
Blood Advances|August 31, 2022
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopeniaAnton Ilich, Terry B Gernsheimer, Darrell J Triulzi, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Transfusion|September 12, 2018
Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopeniaSherrill J Slichter, Larry J Dumont, Jose A Cancelas, et al.
American Journal of Hematology|January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B StudyNichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Leukemia & Lymphoma|September 14, 2020
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Nicholas P Howard, et al.
The Journal of Trauma and Acute Care Surgery|May 27, 2021
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus ConferencePhilip C Spinella, Nahed El Kassar, Andrew P Cap, et al.
Blood|October 23, 2009
International consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Roberto Stasi, Adrian C Newland, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Leukemia|October 6, 2019
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasmAnna B Halpern, Nicholas P Howard, Megan Othus, et al.
Pageof 4